| UniProt ID | H13_HUMAN | |
|---|---|---|
| UniProt AC | P16402 | |
| Protein Name | Histone H1.3 | |
| Gene Name | HIST1H1D | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 221 | |
| Subcellular Localization | Nucleus. Chromosome. According to PubMed:15911621 more commonly found in euchromatin. According to PubMed:10997781 is associated with inactive chromatin. | |
| Protein Description | Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity).. | |
| Protein Sequence | MSETAPLAPTIPAPAEKTPVKKKAKKAGATAGKRKASGPPVSELITKAVAASKERSGVSLAALKKALAAAGYDVEKNNSRIKLGLKSLVSKGTLVQTKGTGASGSFKLNKKAASGEGKPKAKKAGAAKPRKPAGAAKKPKKVAGAATPKKSIKKTPKKVKKPATAAGTKKVAKSAKKVKTPQPKKAAKSPAKAKAPKPKAAKPKSGKPKVTKAKKAAPKKK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSETAPLAP ------CCCCCCCCC | 43.59 | 21406692 | |
| 2 | Phosphorylation | ------MSETAPLAP ------CCCCCCCCC | 43.59 | 23401153 | |
| 4 | Phosphorylation | ----MSETAPLAPTI ----CCCCCCCCCCC | 26.69 | 23401153 | |
| 10 | Phosphorylation | ETAPLAPTIPAPAEK CCCCCCCCCCCCCCC | 33.70 | 23401153 | |
| 17 | Acetylation | TIPAPAEKTPVKKKA CCCCCCCCCCCHHHH | 61.30 | 23749302 | |
| 17 | Methylation | TIPAPAEKTPVKKKA CCCCCCCCCCCHHHH | 61.30 | 17043054 | |
| 17 | Ubiquitination | TIPAPAEKTPVKKKA CCCCCCCCCCCHHHH | 61.30 | 22817900 | |
| 18 | Phosphorylation | IPAPAEKTPVKKKAK CCCCCCCCCCHHHHH | 25.48 | 29255136 | |
| 21 | Ubiquitination | PAEKTPVKKKAKKAG CCCCCCCHHHHHHCC | 50.16 | 33845483 | |
| 22 | Ubiquitination | AEKTPVKKKAKKAGA CCCCCCHHHHHHCCC | 59.19 | 22817900 | |
| 30 | Phosphorylation | KAKKAGATAGKRKAS HHHHCCCCCCCCCCC | 34.72 | 26074081 | |
| 33 | Acetylation | KAGATAGKRKASGPP HCCCCCCCCCCCCCC | 48.54 | 7708193 | |
| 35 | Acetylation | GATAGKRKASGPPVS CCCCCCCCCCCCCHH | 50.84 | 17043054 | |
| 35 | Glycation | GATAGKRKASGPPVS CCCCCCCCCCCCCHH | 50.84 | - | |
| 35 | Methylation | GATAGKRKASGPPVS CCCCCCCCCCCCCHH | 50.84 | - | |
| 35 | Other | GATAGKRKASGPPVS CCCCCCCCCCCCCHH | 50.84 | 27105115 | |
| 35 | Ubiquitination | GATAGKRKASGPPVS CCCCCCCCCCCCCHH | 50.84 | 32142685 | |
| 37 | Phosphorylation | TAGKRKASGPPVSEL CCCCCCCCCCCHHHH | 55.67 | 29255136 | |
| 42 | Phosphorylation | KASGPPVSELITKAV CCCCCCHHHHHHHHH | 32.24 | 30266825 | |
| 46 | Phosphorylation | PPVSELITKAVAASK CCHHHHHHHHHHHHH | 26.10 | 30266825 | |
| 47 | Ubiquitination | PVSELITKAVAASKE CHHHHHHHHHHHHHH | 33.59 | 21890473 | |
| 47 | Acetylation | PVSELITKAVAASKE CHHHHHHHHHHHHHH | 33.59 | 22641323 | |
| 47 | Glycation | PVSELITKAVAASKE CHHHHHHHHHHHHHH | 33.59 | - | |
| 47 | Other | PVSELITKAVAASKE CHHHHHHHHHHHHHH | 33.59 | 27105115 | |
| 47 | Ubiquitination | PVSELITKAVAASKE CHHHHHHHHHHHHHH | 33.59 | 25015289 | |
| 52 | Phosphorylation | ITKAVAASKERSGVS HHHHHHHHHHCCCCC | 25.88 | 26546556 | |
| 53 | Acetylation | TKAVAASKERSGVSL HHHHHHHHHCCCCCH | 53.04 | 7296757 | |
| 53 | Other | TKAVAASKERSGVSL HHHHHHHHHCCCCCH | 53.04 | 27105115 | |
| 53 | Ubiquitination | TKAVAASKERSGVSL HHHHHHHHHCCCCCH | 53.04 | 23000965 | |
| 55 | Citrullination | AVAASKERSGVSLAA HHHHHHHCCCCCHHH | 42.31 | - | |
| 55 | Citrullination | AVAASKERSGVSLAA HHHHHHHCCCCCHHH | 42.31 | - | |
| 55 | Methylation | AVAASKERSGVSLAA HHHHHHHCCCCCHHH | 42.31 | - | |
| 56 | Phosphorylation | VAASKERSGVSLAAL HHHHHHCCCCCHHHH | 44.64 | 30266825 | |
| 59 | Phosphorylation | SKERSGVSLAALKKA HHHCCCCCHHHHHHH | 18.80 | 30266825 | |
| 64 | Acetylation | GVSLAALKKALAAAG CCCHHHHHHHHHHCC | 31.13 | 163887 | |
| 64 | Ubiquitination | GVSLAALKKALAAAG CCCHHHHHHHHHHCC | 31.13 | 23000965 | |
| 65 | Ubiquitination | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | 21890473 | |
| 65 | Sumoylation | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | - | |
| 65 | Acetylation | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | - | |
| 65 | Methylation | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | - | |
| 65 | Other | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | 27105115 | |
| 65 | Sumoylation | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | - | |
| 65 | Ubiquitination | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | 23000965 | |
| 72 | Phosphorylation | KALAAAGYDVEKNNS HHHHHCCCCCHHCCC | 16.46 | 28152594 | |
| 76 | Ubiquitination | AAGYDVEKNNSRIKL HCCCCCHHCCCCCCC | 62.37 | 21890473 | |
| 76 | Acetylation | AAGYDVEKNNSRIKL HCCCCCHHCCCCCCC | 62.37 | 158555 | |
| 76 | Other | AAGYDVEKNNSRIKL HCCCCCHHCCCCCCC | 62.37 | 27105115 | |
| 76 | Ubiquitination | AAGYDVEKNNSRIKL HCCCCCHHCCCCCCC | 62.37 | 23000965 | |
| 79 | Phosphorylation | YDVEKNNSRIKLGLK CCCHHCCCCCCCCHH | 44.79 | 23401153 | |
| 82 | Ubiquitination | EKNNSRIKLGLKSLV HHCCCCCCCCHHHHH | 35.08 | 23000965 | |
| 86 | Ubiquitination | SRIKLGLKSLVSKGT CCCCCCHHHHHHCCC | 39.69 | 21890473 | |
| 86 | Acetylation | SRIKLGLKSLVSKGT CCCCCCHHHHHHCCC | 39.69 | 72630449 | |
| 86 | Other | SRIKLGLKSLVSKGT CCCCCCHHHHHHCCC | 39.69 | 27105115 | |
| 86 | Ubiquitination | SRIKLGLKSLVSKGT CCCCCCHHHHHHCCC | 39.69 | 23000965 | |
| 87 | Phosphorylation | RIKLGLKSLVSKGTL CCCCCHHHHHHCCCE | 38.76 | 20860994 | |
| 90 | Phosphorylation | LGLKSLVSKGTLVQT CCHHHHHHCCCEEEE | 30.57 | 17877366 | |
| 91 | Ubiquitination | GLKSLVSKGTLVQTK CHHHHHHCCCEEEEC | 48.73 | 21890473 | |
| 91 | Acetylation | GLKSLVSKGTLVQTK CHHHHHHCCCEEEEC | 48.73 | 7692547 | |
| 91 | Other | GLKSLVSKGTLVQTK CHHHHHHCCCEEEEC | 48.73 | 27105115 | |
| 91 | Ubiquitination | GLKSLVSKGTLVQTK CHHHHHHCCCEEEEC | 48.73 | 23000965 | |
| 93 | Phosphorylation | KSLVSKGTLVQTKGT HHHHHCCCEEEECCC | 27.74 | 17877366 | |
| 97 | Phosphorylation | SKGTLVQTKGTGASG HCCCEEEECCCCCCC | 24.78 | 28111955 | |
| 98 | Ubiquitination | KGTLVQTKGTGASGS CCCEEEECCCCCCCC | 37.07 | 21890473 | |
| 98 | Acetylation | KGTLVQTKGTGASGS CCCEEEECCCCCCCC | 37.07 | - | |
| 98 | Methylation | KGTLVQTKGTGASGS CCCEEEECCCCCCCC | 37.07 | - | |
| 98 | Ubiquitination | KGTLVQTKGTGASGS CCCEEEECCCCCCCC | 37.07 | 23000965 | |
| 100 | Phosphorylation | TLVQTKGTGASGSFK CEEEECCCCCCCCEE | 31.00 | 26657352 | |
| 103 | Phosphorylation | QTKGTGASGSFKLNK EECCCCCCCCEEECC | 35.99 | 21712546 | |
| 105 | Phosphorylation | KGTGASGSFKLNKKA CCCCCCCCEEECCCC | 19.40 | 23401153 | |
| 107 | Ubiquitination | TGASGSFKLNKKAAS CCCCCCEEECCCCCC | 53.50 | 21890473 | |
| 107 | Acetylation | TGASGSFKLNKKAAS CCCCCCEEECCCCCC | 53.50 | 22641329 | |
| 107 | Methylation | TGASGSFKLNKKAAS CCCCCCEEECCCCCC | 53.50 | - | |
| 107 | Other | TGASGSFKLNKKAAS CCCCCCEEECCCCCC | 53.50 | 27105115 | |
| 107 | Ubiquitination | TGASGSFKLNKKAAS CCCCCCEEECCCCCC | 53.50 | 21906983 | |
| 110 | Ubiquitination | SGSFKLNKKAASGEG CCCEEECCCCCCCCC | 54.98 | 22817900 | |
| 111 | Ubiquitination | GSFKLNKKAASGEGK CCEEECCCCCCCCCC | 48.38 | 22817900 | |
| 114 | Phosphorylation | KLNKKAASGEGKPKA EECCCCCCCCCCCCH | 42.09 | 24825855 | |
| 118 | Ubiquitination | KAASGEGKPKAKKAG CCCCCCCCCCHHHCC | 38.76 | 33845483 | |
| 141 | Lactylation | GAAKKPKKVAGAATP CCCCCCCCCCCCCCC | 45.93 | 31645732 | |
| 141 | Ubiquitination | GAAKKPKKVAGAATP CCCCCCCCCCCCCCC | 45.93 | 33845483 | |
| 147 | Phosphorylation | KKVAGAATPKKSIKK CCCCCCCCCCHHCCC | 34.80 | 22167270 | |
| 149 | Ubiquitination | VAGAATPKKSIKKTP CCCCCCCCHHCCCCC | 55.59 | 33845483 | |
| 151 | Phosphorylation | GAATPKKSIKKTPKK CCCCCCHHCCCCCCC | 45.85 | 28111955 | |
| 155 | Phosphorylation | PKKSIKKTPKKVKKP CCHHCCCCCCCCCCC | 35.03 | 15595731 | |
| 160 | Ubiquitination | KKTPKKVKKPATAAG CCCCCCCCCCCCHHC | 63.02 | 29967540 | |
| 161 | Ubiquitination | KTPKKVKKPATAAGT CCCCCCCCCCCHHCH | 42.76 | 33845483 | |
| 164 | Phosphorylation | KKVKKPATAAGTKKV CCCCCCCCHHCHHHH | 26.10 | 20860994 | |
| 168 | Phosphorylation | KPATAAGTKKVAKSA CCCCHHCHHHHHHHH | 23.98 | 21406692 | |
| 169 | Acetylation | PATAAGTKKVAKSAK CCCHHCHHHHHHHHC | 44.31 | 17043054 | |
| 169 | Ubiquitination | PATAAGTKKVAKSAK CCCHHCHHHHHHHHC | 44.31 | 33845483 | |
| 170 | Acetylation | ATAAGTKKVAKSAKK CCHHCHHHHHHHHCC | 47.46 | 24847165 | |
| 170 | Methylation | ATAAGTKKVAKSAKK CCHHCHHHHHHHHCC | 47.46 | 17043054 | |
| 170 | Other | ATAAGTKKVAKSAKK CCHHCHHHHHHHHCC | 47.46 | 27105115 | |
| 173 | Acetylation | AGTKKVAKSAKKVKT HCHHHHHHHHCCCCC | 54.67 | 24847173 | |
| 176 | Acetylation | KKVAKSAKKVKTPQP HHHHHHHCCCCCCCC | 66.25 | 24847181 | |
| 179 | Acetylation | AKSAKKVKTPQPKKA HHHHCCCCCCCCHHH | 64.47 | 25953088 | |
| 179 | Ubiquitination | AKSAKKVKTPQPKKA HHHHCCCCCCCCHHH | 64.47 | 33845483 | |
| 180 | Phosphorylation | KSAKKVKTPQPKKAA HHHCCCCCCCCHHHC | 30.09 | 28674151 | |
| 188 | Acetylation | PQPKKAAKSPAKAKA CCCHHHCCCCHHHCC | 62.93 | 164433 | |
| 189 | Phosphorylation | QPKKAAKSPAKAKAP CCHHHCCCCHHHCCC | 25.93 | 16377619 | |
| 207 | Acetylation | AAKPKSGKPKVTKAK CCCCCCCCCCCCCCH | 49.08 | 163959 | |
| 209 | Acetylation | KPKSGKPKVTKAKKA CCCCCCCCCCCCHHC | 67.05 | 158577 | |
| 212 | Acetylation | SGKPKVTKAKKAAPK CCCCCCCCCHHCCCC | 62.28 | 158347 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 105 | S | Phosphorylation | Kinase | PKC | - | Uniprot |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 55 | R | Citrullination |
| - |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of H13_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of H13_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Human spleen histone H1. Isolation and amino acid sequences of threeminor variants, H1a, H1c, and H1d."; Ohe Y., Hayashi H., Iwai K.; J. Biochem. 106:844-857(1989). Cited for: PROTEIN SEQUENCE OF 2-221. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND MASSSPECTROMETRY. | |
| "Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18 AND SER-37, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-4 AND THR-18, AND MASSSPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-180, AND MASSSPECTROMETRY. | |